Jingwu Zang, I-Mab founder and chairman
May 19, 2021 06:00 PM EDTUpdated May 20, 01:20 AM
R&D

#AS­CO21: Ab­b­Vie-part­nered Chi­nese biotech with first-in-class am­bi­tions show­cas­es ear­ly da­ta on CD73 an­ti­body

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

GSK awaits Nu­cala de­ci­sion af­ter FDA tar­get date pass­es

Take­da an­nounces hand­ful of pipeline cuts in ef­fort to ‘piv­ot re­sources’

'Find a way, or make one': How two sci­en­tists hope to re­vi­tal­ize CRISPR's rare dis­ease cri­sis

As­traZeneca los­es ap­peals court fight over IRA drug price ne­go­ti­a­tions

AI-fo­cused biotech in­sitro cuts 22% of staff, cit­ing 'tu­mul­tuous mar­ket'

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times